Insmed (INSM) Net Margin (2010 - 2026)

Insmed's Net Margin history runs 12 years deep, the most recent figure standing at 53.46% for Q1 2026.

• In Q1 2026, Net Margin rose 22296.0% year-over-year to 53.46%; the TTM figure through Mar 2026 stood at 144.44% (up 12149.0% YoY), while the FY2025 annual figure was 210.54%, up 4070.0% from the prior year.
• Net Margin for Q1 2026 stood at 53.46%, up from 124.5% in the prior quarter.
• The five-year high for Net Margin was 53.46% in Q1 2026, with the low at 332.75% in Q2 2024.
• The 5-year median for Net Margin is 225.53% (2024), against an average of 222.94%.
• The sharpest annual moves came in 2023 and 2026: Net Margin tumbled 17034 bps in 2023, then jumped 22296 bps in 2026.
• Insmed's Net Margin stood at 270.02% in 2022, then rose by 18 bps to 222.31% in 2023, then dropped by 1 bps to 225.53% in 2024, then soared by 45 bps to 124.5% in 2025, then soared by 57 bps to 53.46% in 2026.
• Business Quant data shows INSM's Net Margin at 53.46% in Q1 2026, 124.5% in Q4 2025, and 259.95% in Q3 2025.